Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins

Journal of Urology

Volumn 172, Issue 2, 2004, Pages 520-524

  Freedland, Stephen J ^a   Terris, Martha K ^b   Presti Jr , Joseph C ^c   Amling, Christopher L ^d   Kane, Christopher J ^e,f   Trock, Bruce ^a   Aronson, William J ^g  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^e SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

African Americans; Obesity; Prostatectomy; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BODY MASS; CANCER RECURRENCE; CANCER SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE DISEASE; PROSTATECTOMY; TREATMENT OUTCOME;

EID: 3142654229     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000135302.58378.ae     Document Type: Article

References (20)

1. Flegal, K. M., Carroll, M. D., Ogden, C. L. and Johnson, C. L.: Prevalence and trends in obesity among US adults, 1999-2000. JAMA, 288: 1723, 2002
2. Bray, G. A.: The underlying basis for obesity: relationship to cancer. J Nutr, 132: 3451S, 2002
3. Giovannucci, E., Rimm, E. B., Liu, Y., Leitzmann, M., Wu, K., Stampfer, M. J. et al: Body mass index and risk of prostate cancer in U.S. health professionals. J Natl Cancer Inst, 95: 1240, 2003
4. Calle, E. E., Rodriguez, C., Walker-Thurmond, K. and Thun, M. J.: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U. S. adults. N Engl J Med, 348: 1625, 2003
5. Snowdon, D. A., Phillips, R. L. and Choi, W.: Diet, obesity, and risk of fatal prostate cancer. Am J Epidemiol, 120: 244, 1984
6. Rodriguez, C., Patel, A. V., Calle, E. E., Jacobs, E. J., Chao, A. and Thun, M. J.: Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiol Biomarkers Prev, 10: 345, 2001
7. Freedland, S. J., Aronson, W. J., Kane, C. J., Presti, J. C., Jr., Amling, C. L., Elashoff, D. et al: Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group. J Clin Oncol, 22: 446, 2004
8. Amling, C. L., Kane, C. J., Riffenburgh, R. H., Ward, J. F., Roberts, J. L., Lance, R. S. et al: Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy. Urology, 58: 723, 2001
9. Mydlo, J. H., Tieng, N. L., Volpe, M. A., Chaiken, R. and Kral, J. G.: A pilot study analyzing PSA, serum testosterone, lipid profile, body mass index and race in a small sample of patients with and without carcinoma of the prostate. Prostate Cancer Prostatic Dis, 4: 101, 2001
10. Rohrmann, S., Roberts, W. W., Walsh, P. C. and Platz, E. A.: Family history of prostate cancer and obesity in relation to high-grade disease and extraprostatic extension in young men with prostate cancer. Prostate, 55: 140, 2003
11. Amling, C. J., Riffenburgh, R. H., Sun, L., Moul, J. W., Lance, R. S., Kusuda, L. et al: Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol, 22: 439, 2004
12. Pasquali, R., Casimirri, F., Cantobelli, S., Melchionda, N., Morselli Labate, A. M., Fabbri, R. et al: Effect of obesity and body fat distribution on sex hormones and insulin in men. Metabolism, 40: 101, 1991
13. Vermeulen, A., Kaufman, J. M., Geomaere, S. and van Pottelberg, I.: Estradiol in elderly men. Aging Male, 5: 98, 2002
14. Thompson, I. M., Goodman, P. J., Tangen, C. M., Lucia, M. S., Miller, G. J., Ford, L. G. et al: The influence of finasteride on the development of prostate cancer. N Engl J Med, 349: 215, 2003
15. Roehrborn, C. G., Lee, M., Meehan, A., Waldstreicher, J. and PLESS Study Group: Effects of finasteride on serum testosterone and body mass index in men with benign prostatic hyperplasia. Urology, 62: 894, 2003
16. Geller, J.: Effect of finasteride, a 5 alpha-reductase inhibitor on prostate tissue androgens and prostate-specific antigen. J Clin Endocrinol Metab, 71: 1552, 1990
17. Castro-Magana, M., Angulo, M., Fuentes, B., Canas, A., Sarrantonio, M., Arguello, R. et al: Effect of finasteride on human testicular steroidogenesis. J Androl, 17: 516, 1996
18. Massengill, J. C., Sun, L., Moul, J. W., Wu, H., McLeod, D. G., Amling, C. et al: Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy. J Urol, 169: 1670, 2003
19. Freedland, S. J., Amling, C. L., Dorey, F., Kane, C. J., Presti, J. C., Jr., Terris, M. K. et al: Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Urology, 60: 670, 2002
20. Powell, I. J., Banerjee, M., Novallo, M., Sakr, W., Grignon, D., Wood, D. P. et al: Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease. Urology, 55: 246, 2000